Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 116939
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.116939
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.116939
Figure 1 Comparison of immune outcomes after intramuscular vs mucosal vaccination.
NALT: Nasal-associated lymphoid tissue.
Figure 2 Proposed prime → mucosal boost strategy illustrated along the respiratory immune axis.
- Citation: Younas S, Farooq S, Sahu S, Mwita RP, Özdemir Ö. Next-generation mucosal vaccines for respiratory viruses: Immunological correlates, platform design and clinical translation. World J Virol 2026; 15(1): 116939
- URL: https://www.wjgnet.com/2220-3249/full/v15/i1/116939.htm
- DOI: https://dx.doi.org/10.5501/wjv.v15.i1.116939
